Singapore-based medical testing firm Mirxes joins Jiangsu Hengrui Pharmaceuticals in revitalised market’s listing surge.

Hong Kong's IPO market has been heating up in recent months, with Chinese companies considering a second listing in the financial hub. Increased activity from A-share companies has supported an ...

Pony AI Inc has confidentially filed for Hong Kong IPO to raise capital for expansion. Its stock surged and caught fire for ...

(Reuters) -Chinese drug developer and producer Jiangsu Hengrui Pharmaceuticals is seeking to raise up to HK$9.89 billion ($1.27 billion) in a Hong Kong initial public offering, according to a ...

This digital payment services provider is likely to get a lift from China's initiatives to boost domestic consumption.

China’s Zijin Mining Group (OTCPK:ZIJMF) (OTCPK:ZIJMY) has picked Citic Securities Co. and Morgan Stanley (MS) to lead the ...

The world’s biggest IPO this year excludes U.S. onshore investors. The decision reduces geopolitical risks that loom over ...

SINGAPORE] Companies have been flocking to file applications for initial public offerings (IPOs) in Hong Kong amid ...

World’s largest maker of electric-vehicle batteries could expand its IPO deal to as much as US$5.3 billion if several upsize options are exercised.

The move signals strong momentum for Hong Kong's IPO market, despite the ongoing global economic uncertainties fueled by ...

Artificial intelligence-driven drug firm METiS Pharmaceuticals is considering an initial public offering in Hong Kong to ...

Xpeng Inc. is considering an initial public offering for its flying car unit, Xpeng Aeroht, according to people familiar with ...